Konica Minolta Healthcare Americas, Inc., is pleased to announce the publication of a case study by clinicians in the pulmonary and radiology departments at ASST Fatebenefratelli Sacco (Milan, Italy) ...
Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.
The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.
Maybe you've been in a room recently with someone who's coughing, but they say "I promise it's not COVID." While it's important to still be cautious about COVID-19, there are other viral ...
A new study, which has found that Covid-19, caused by the Sars-CoV-2 virus is linked to accelerated plaque buildup in the ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...